TABLE 1

Outcomes of pulmonary endarterectomy in patients with proximal (type 1 and type 2) or distal (type 3) chronic thromboembolic pulmonary hypertension (CTEPH) disease distribution

ProximalDistal
Subjects n221110
mPAP mmHg
 Pre-operative44±1046±11
 At discharge22±724±6
 3-month follow-up24±925±7
 12-month follow-up23±724±8
 p-value#<0.001<0.001
PVR dyn·s·cm–5
 Pre-operative876±392926±337
 At discharge251±146295±161
 3-month follow-up270±175300±139
 12-month follow-up243±115300±224
 p-value#<0.001<0.001
PaO2 mmHg
 Pre-operative65±1266±11
 3-month follow-up82±1380±11
 12-month follow-up80±1180±11
 p-value#<0.001<0.001
Modified Bruce exercise test m
 Pre-operative51 (0−143)52 (0−102)
 3-month follow-up495 (182−658)435 (143−586)
 12-month follow-up520 (261−709)474 (225−620)
 p-value#<0.001<0.001
6-min walking distance m
 Pre-operative277±118289±112
 3-month follow-up391±118398±107
 12-month follow-up389±118396±112
 p-value#<0.001<0.001
  • Data are presented as mean±sd or median (interquartile range), unless otherwise stated. mPAP: mean pulmonary arterial pressure; PVR: pulmonary vascular resistance; PaO2: arterial oxygen tension. Tests of interaction are as follows. mPAP: p=0.975; PVR: p=0.777; PaO2: p=0.317; modified Bruce exercise test: p=0.205; 6-min walking distance: p=0.962. #: versus pre-operative. Reproduced and modified from [24] with permission from the publisher.